Aethlon medical to present at virtual investor conferences in september

San diego , sept. 17, 2024 /prnewswire/ -- aethlon medical, inc.  (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that management will present at the following virtual investor conferences in september: september 19-20: life sciences investor forum: james frakes, interim chief executive officer and chief financial officer and steven larosa, md, chief medical officer, will present a company overview at this conference, hosted by virtualinvestorconferences.com, on thursday, september 19, 2024 at 1:30 pm et.
AEMD Ratings Summary
AEMD Quant Ranking